Comparison of the effect of Remazolam toluenesulfonate combined with esketamine and propofol combined with esketamine in pediatric anesthesia

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300076718

Enrollment

Unknown

Registered

2023-10-17

Start date

2023-10-20

Completion date

Unknown

Last updated

2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium

Interventions

Tset group:remimazolam tosilate combined with esketamine

Control group:propofol combined with esketamine

Eligibility

Sex/Gender

All

Age

2 Years to 8 Years

Inclusion criteria

Inclusion criteria: 1. Children undergoing abdominal surgery at selected time; 2. Children 2-8 years old; 3. ASA I-II level;

Exclusion criteria

Exclusion criteria: 1. Paediatric population in need of special care or supervision by courts/social welfare institutions; 2. Children who had undergone general anesthesia within 14 days before randomization; 3. Complicated with serious cardiovascular system diseases; 4. Subjects with mental system diseases and cognitive dysfunction; Children with a history of epilepsy; 5. Other conditions deemed unsuitable for participation in this clinical trial by the investigator.

Design outcomes

Primary

Measure	Time frame
PAED score;Incidence of adverse reactions during recovery;	—

Secondary

Measure	Time frame
vital signs at different times;BIS values at different times;	—

Countries

China

Contacts

Public ContactLi Zhe

Department of Anesthesiology, the Second Affiliated Hospital of Xi 'an Jiaotong University

344623100@qq.com+86 188 4607 4850

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026